Company: PCAP
Filing Date: 2025-05-22
Form Type: 424B4
Source: 0001213900-25-046578
Chunk: 16

Company: ProCap Acquisition Corp
Filing Date: 2025-05-22
Form: 424B4
Chunk 16
---
Fast Solutions Group, the leading master distributor of fasteners in North America. Mr.Buchanan then served as Executive Vice President and Chief Operating Officer of LindFast Solutions Group from July 2022 to October 2024. Prior to his time at LindFast Solutions Group, Mr.Buchanan served as the Chief Financial Officer of US Greenfiber, a cellulose insulation manufacturer, from July 2018 to August 2019. Additionally, Mr.Buchanan has served on the board of directors of Argus Monitoring Solutions since February 2022. Mr.Buchanan earned a degree in Economics from Samford University and an MBA from the University of Kentucky. We believe Mr.Buchanan is well qualified to serve as a member of our board of directors due to his extensive strategic, operational and broad business experience. Brent Saunders is serving as a Special Advisor to the Company. Mr. Saunders has served on the board of directors of TBHC since May 4, 2021 and currently serves as its chairman of the board. Mr. Saunders briefly served as Interim Chief Executive Officer of TBHC in January and February 2022, and as TBHC’s executive chairman of the board of directors for the fiscal year of 2022 until March 2023. Mr. Saunders has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Mr. Saunders served as Chairman, President and Chief Executive Officer of Allergan plc (“Allergan”), an American, Irish -domiciledpharmaceutical company. His role as president and chief executive officer of Allergan began in July 2014 and his added role of chairman began in October 2016. Mr. Saunders’ first role as an executive officer in the pharmaceuticals and healthcare sectors began in 2003, as a member of the executive management team at Schering -PloughCorporation (“Schering -Plough”), where he held several key roles, including president of the company’s Global Consumer Health Care division. While at Schering -Plough, Mr. Saunders led the integrations of the company’s $14 billion acquisition of 4 Organon Biosciences N.V. in 2007 as well as the merger between Schering -Ploughand Merck & Co., Inc. in 2009. From March 2010 until August